The immune landscape is a strong predictive biomarker for clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status

Category Primary study
JournalInternational Journal of Gynecological Cancer
Year 2019
This article has no abstract
Epistemonikos ID: 5b9a662c6cae6a1a4687e1a89246cdf00b0fb1e1
First added on: Feb 11, 2025